Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Aquadopa Bets on Dopamine in an Over-Caffeinated Industry
  • USA - English


News provided by

MCFADDEN/GAVENDER

Jun 13, 2014, 09:00 ET

Share this article

Share toX

Share this article

Share toX

logo
logo

Albuquerque, N.M. (PRWEB) June 13, 2014 -- Mucuna pruriens, an under recognized herb in western culture, brings hope to the booming, yet stigmatized, energy drink industry with the introduction of a new herbal supplement: Aquadopa. Aimed at stimulating focus, motivation and mood, Aquadopa was created by dopamine expert Dr. Andrew Hemmen and uses Mucuna Pruriens as a primary ingredient to deliver customers an experience beyond just energy.

...when we feel rejuvenated, when we feel uplifted, strong and clear, that’s when opportunities emerge. And from that vantage point, creativity can follow.

Post this

What is mucuna pruriens? Put simply, an herb native to tropical climates that is the only known naturally occurring source of levodopa, or L-dopa, a biochemical precursor for the brain hormone and neurotransmitter dopamine. Dopamine is the key brain chemical responsible for feelings of satisfaction, reward and motivation.

Practitioners of the ancient Hindu traditional medicine Ayurvedic have used mucuna pruriens for centuries for treatment of a variety of ailments, including Parkinson’s disease. A 2003 study by researchers in England showed the natural L-dopa in mucuna pruriens may work faster than a synthetic version of L-dopa in the treatment of Parkinson’s patients.

Aquadopa is an herbal supplement beverage that provides numerous benefits from its main ingredient – mucuna pruriens, and its supplemental ingredients: ginkgo biloba, which increases blood flow to the brain; taurine, an amino acid that helps provide energy; and tyrosine, which is an amino acid that is a precursor to dopamine production.

All of these combined helps the Aquadopa consumer have greater mental sharpness and enhanced creativity, greater motivation and focus, leaner muscle mass, increased libido and an overall increase in energy.

“People are working harder and they’re working longer. People are putting greater and greater demands on themselves. With all this repetitive stress and demand, it’s no wonder we sometimes fall short. But when we feel rejuvenated, when we feel uplifted, strong and clear, that’s when opportunities emerge. And from that vantage point, creativity can follow,” said Dr. Hemmen, a board-certified internal medicine physician. “It’s all about the vision, the focus and the execution, again and again.

“I created Aquadopa as an herbal supplement to enhance the brain’s dopamine system. I find dopamine as the most fascinating chemical in our brains. It enables our motivation and reward system. I believe it is dopamine that has driven humanity to the success it has achieved,” Dr. Hemmen said.

“It enables our executive functions. That means thinking into the future, seeing ahead, and then planning and acting on those plans to reach our goals.”
While there are pill versions of mucuna pruriens, Aquadopa is the first supplemental drink that has been built around a significant dose of mucuna pruriens and with “dopamine enhancement” as its primary function.

Aquadopa is available at Sprouts Farmers Market or through Amazon.com.

To interview Dr. Andrew Hemmen, for more information or product samples of Aquadopa, please call the media contacts below.

These statements have not been evaluated by the Food and Drug Administration. Aquadopa is not intended to diagnose, treat, cure or prevent any disease.

ABOUT AQUADOPA
Aquadopa is an herbal supplement beverage that is a natural alternative to sugary energy drinks. It enhances mood, energy, motivation and creativity. Aquadopa is derived from the ancient Indian herb mucuna pruriens with tyrosine, ginkgo biloba and taurine. In 2011, Dr. Andrew Hemmen, board certified in internal medicine, became interested in the neurochemistry associated with motivation and success. He began to consider natural ways to support and enhance the motivation and reward system, based on natural herbs and amino acids. The concept of Aquadopa – to take people “beyond energy” – was born. For more information, go to http://www.aquadopa.com.

MEDIA CONTACTS:
Jeremy Belitsos
McFadden/Gavender
O: (520) 882-6262
M: (520) 332-3732
jeremyb(at)mcfaddengavender(dot)com

Diego Romero
McFadden/Gavender
O: (520) 882-6262
M: (520) 401-1693
diego(at)mcfaddengavender(dot)com

Website:
http://www.aquadopa.com

Jeremy Andrew Belitsos, MCFADDEN/GAVENDER, +1 5208826262, [email protected]

Modal title

View PDF
View PDF

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.